TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 92 filers reported holding TRICIDA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,975 | -98.5% | 58,700 | 0.0% | 0.00% | – |
| Q3 2022 | $615,000 | +8.3% | 58,700 | 0.0% | 0.00% | – |
| Q2 2022 | $568,000 | +56.0% | 58,700 | -14.7% | 0.00% | – |
| Q1 2021 | $364,000 | -22.2% | 68,800 | +3.6% | 0.00% | – |
| Q4 2020 | $468,000 | -22.3% | 66,400 | 0.0% | 0.00% | – |
| Q3 2020 | $602,000 | -67.0% | 66,400 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $1,825,000 | +115.5% | 66,400 | +72.5% | 0.00% | +100.0% |
| Q1 2020 | $847,000 | -40.6% | 38,500 | +1.9% | 0.00% | 0.0% |
| Q4 2019 | $1,427,000 | +25.6% | 37,800 | +2.7% | 0.00% | 0.0% |
| Q3 2019 | $1,136,000 | -19.8% | 36,800 | +2.5% | 0.00% | -50.0% |
| Q2 2019 | $1,417,000 | +40.6% | 35,900 | +37.5% | 0.00% | +100.0% |
| Q1 2019 | $1,008,000 | +63.9% | 26,100 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $615,000 | – | 26,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 7,132,079 | $69,039,000 | 13.60% |
| STONEHILL CAPITAL MANAGEMENT LLC | 1,436,736 | $13,908,000 | 9.25% |
| COMMODORE CAPITAL LP | 2,028,453 | $19,635,000 | 4.15% |
| Tri Locum Partners LP | 731,142 | $7,077,000 | 2.90% |
| GREAT POINT PARTNERS LLC | 1,164,763 | $11,275,000 | 2.70% |
| Frazier Life Sciences Management, L.P. | 2,082,093 | $20,155,000 | 1.90% |
| Orbimed Advisors | 10,280,947 | $99,520,000 | 1.80% |
| Deep Track Capital, LP | 2,732,117 | $26,447,000 | 1.74% |
| Lion Point Capital, LP | 1,826,729 | $12,034,000 | 1.37% |
| Bleichroeder LP | 450,000 | $4,356,000 | 0.90% |